HEAD BRIDGE MARKET
ARIARIA MARKET
OGBETE MAIN MARKET
SABONGARI KANO
OSHODI MARKET
EKEUKWU OWERRI MARKET
LAGOS ISLAND MARKET
ETC
These are some of the notable market we will be waiting to see the government to sale of drugs by June 2013.
Friday, 30 August 2013
Friday, 25 January 2013
LIST OF PHARMACEUTICAL COMPANIES IN NIGERIA
PHARMACEUTICAL COMPANIES IN NIGERIA
Aboseldehyde limitedAddress: Plot C20, LSDPC Amuwo Odofin Scheme, Commercial Layout,
Apapa/Oshodi E/Way, Lagos.
Phone: +234 1 496 7251, 493 1811;
Fax: +234 1 967 251
Afrab-Chem LimitedAddress: 22, Abimbola Street, Isolo Industrial Estate,
Isolo, Lagos.
Phone: +234 1 452 2571, 452 2777;
Fax: +234 1 452 0328.
Website: http://www.afrabchem.com
Afrik Pharmaceuticals LimitedAddress: 1, Afrik Road, Awo-Omamma,
Imo State.
Phone: +234 8 350 1089,
Amexco Pharmaceutical Company LimitedAddress: 2B, Buraimoh Street,
Abule Okuta, Lagos.
Phone: +234 1 775 3511.
BCN LimitedAddress: Plots 22/23, Chief T. A. Doherty Layout, Oregun Industrial Estate,
Ikeja, Lagos.
Phone: +234 1 496 1765, 811 6091;
Fax: +234 1 496 1765.
E-mail: info@bcnplc.com
Website: http://www.bcnplc.com
Bond Chemical Industries LimitedAddress: Bond House, 22A, Alafia Street, off Isolo Road,
Isolo, Lagos.
Phone: +234 1 452 1014, 452 2975, 474 7716, 474 4741.
Website: http://www.bond-pharma.com
Capstone Natural Health Center NigeriaAddress: 3, Oshodi-Isolo Expressway, (Opp NAFDAC Office),
OshodiOke, Lagos.
Phone:+234 (0) 803 302 0892, 802 336 2181.
Carrot-Top Drugs LimitedAddress: 59, Tapa Street, Opp LSDPC Housing Estate Entrance Gate,
Ebute-Metta, Lagos.
Phone: +234 1 720 4450, (0) 803 304 6802.
Email: ctdrugs@yahoo.com
Website: http://www.predicte-ng.com
Chemiron International LimitedAddress:Plot 12, Block B, Metal Box Road,
Ogba, Lagos.
Phone:+ 234 1 773 5817.
Email: info@chemiron.org
Website: http://www.chemiron.org
Churchbells Pharma Nigeria LimitedAddress: 22, Creek Road, Apapa, Lagos.
Phone: +234 1 545 5873.
Email: admimisration@4churchbells.com
Dana Drugs Limited.Address: Km 4, Apapa-Oshodi Expressway, Sanya,
Ijesha, Lagos.
Phone: +234 1 773 0054;
Fax: +234 1 776 3376.
Email: pharma@danagroup.com
Website: http://www.danagroup.com
Dizpharm Nigeria LimitedAddress: 13, Creek Road, P.O. Box 221,
Apapa, Lagos.
Phone: +234 1 587 7689;
Fax: +234 1 587 5437.
Doyin Pharma (Nig) LimitedAddress: Plot 5, LSDPC Scheme 2, Km. 2, Badagry Expressway,
Amuwo Odofin, Lagos.
Phone: +234 1 545 1718;
Fax: 234 1 545 2054.
Email: doyin@hyperia.com
Drugfield Pharmaceuticals LimitedAddress: Lynson Chemical Avenue, Km 38, Lagos-Abeokuta E/Way,
Sango-Otta, Ogun State.
Phone: +234 3 972 0602, 721 237, 819 5593;
Fax: +234 3 972 1236.
Email: info@drugfieldpharma.com
Website: http://www.drugfieldpharma.com
Embassy Pharmaceutical And Chemicals LimitedAddress: 41, Ademola Street, Ikoyi, Lagos.
Phone: +234 1 480 0581, 774 1080, 817 1724, 791 9068.
Emzor Pharmaceuticals Limited.Address: Plot 3c, Block A, Aswani Market Road, Isolo/Apapa Exp.way,
Oshodi, Lagos.
Phone: +234 1 452 3570, 452 3721, 452 7160;
Fax: +234 1 452 5288, 452 7160.
Email: customerservice@emzorpharma.com
Website: http://www.emzorpharma.com
Evans Medical LimitedAddress: Plot 6, Abimbola Way, Isolo P.M.B. 1120,
Apapa, Lagos.
Phone: +234 1 790 1401-8 ;
Fax: +234 1 452 9461, 452 9469.
Email: info@evansmedicalplc.com
Website: http://www.evansmedicalplc.com
Farmex Meyer LimitedAddress: Km 38, Lagos-Abeokuta Road, Sango Otta,
Ogun State.
Phone: +234 3 972 2201-3;
Fax: +234 1 493 4879.
Email: savantfarmex@multilinks.com
Fidson Healthcare LimitedAddress: Olabode House, 215/219 Ikorodu Road,
Obanikoro, Lagos.
Phone: +234 1 493 3319;
Fax: +234 1 493 0841.
Website: http://www.fidson.com
Food & Pharma Nig. LimitedAddress: 6, Ijora Causeway, Ijora, P.O.Box 71353,
Victoria Island, Lagos.
Phone: +234 1 471 9460, 480 5064;
Fax: 234 1 493 3166.
GlaxoSmithkline NigeriaAddress: 1, Industrial Avenue, Ilupeju, Lagos.
Phone: +234 1 271 1000;
Fax: +234 1 271 6164, 271 6172.
Email: CustomerCare_ph_nigeria@gsk.com
Website: http://www.gsk.com
Greenlife Pharmaceuticals LimitedAddress: 2, Bank Lane, Off Town Planning Way,
Ilupeju, Lagos.
Phone: +234 1 555 6918, 555 0480.
Gateway Pharm. Company LimitedAddress: Plots 3-8, Housing Corporation Industrial Estate, Ikangba,
Ijebu-Ode, Ogun State.
Phone: +234 3 743 0202;
Fax: +234 3 743 0526.
Gemini Pharma LimitedAddress: Plot 13, Block A, Amuwo-Odofin Industrial Estate,
Apapa-Oshodi Expressway, Lagos.
Phone: +234 1 474 4974, 790 1184.
Email: info@geminipharmltd.com
Website: http://www.geminipharmltd.com
HealthPlus LimitedAddress: 37, Joel Ogunaike Street, Ikeja GRA, Lagos.
Phone: +234 1 433 1777, 473 8654.
Interpharma Industries Nigeria LimitedAddress: 84, Opebi Road, P.O. Box 17262, Ikeja, Lagos.
Phone: +234 1 493 8950.
Jagal PharmaceuticalAddress: 12, Oyinkan Abayomi Drive, Ikoyi, Lagos.
Phone: +234 1 493 0519, 497 0089;
Fax: +234 1 497 0090.
Email: pharm@jagal.com
Website: http://www.jagal.com
Jimah Yusuf Pharm Industries LimitedAddress: 1, Idaomi Avenue, Off Afekhai Street,
Igarra, Edo State.
Phone: +234 5 762 108, 5 762 052, (0) 803 669 2637.
E-mail: jimahyusufpharm@yahoo.com
Justeen Pharmaceuticals Limited.Address: 57B, Coker Road, Ilupeju, Lagos.
Phone: +234 1 774 7929, 555 2617, 476 5156, 897 6757;
Fax: +234 1 555 6989, 271 4699.
Email: justeen2a@yahoo.com
Leady-Pharma Industries LimitedAddress: Plots 3 & 4, Tomori Industrial Estate, Off Idi-Iroko Road,
Ota, Ogun State.
Phone: +234 3 972 2013, 721 013;
Fax: +234 3 972 2013.
E-mail: leadypharmal@yahoo.com
May & Baker Nigeria LimitedAddress: 3/5 Sapara Street, Ikeja Industrial Estate,
Ikeja, Lagos.
Phone:+234 1 496 8130-6, 496 2951;
Fax:+ 234 1 496 2832.
Email: info@maybaker.com.ng
Website: http://www.maybaker.com.ng
Mopson Pharmaceuticals LimitedAddress: 47, Osolo Way, Ajao Estate, Oshodi, Lagos.
Phone: +234 1 452 3237, 452 8462, (0) 802 290 2177.
Email: mopsonpharm@yahoo.co.uk
Morison Industries LimitedAddress: 28/30, Morison Crescent, Oregun Industrial Area,
P. M. B. 21290, Ikeja, Lagos..
Phone: +234 1 496 7627, 774 7428, 474 2573.
Email: miplc@morison-ng.com
Website: http://www.morison-nig.com
Neimeth International Pharmaceuticals LimitedAddress: 1, Henry Carr Street, Ikeja Industrial Estate,P.M.B. 21111,
Ikeja, Lagos.
Phone: +234 1 899 7401-2.
Email: info@neimethplc.com
Website: http://www.neimethplc.com
New Healthway Pharmaceuticals LimitedAddress: Km 22, Lagos-Badagry Expressway,
Ajangbadi, Lagos.
Phone: +234 1 794 3022.
Email: nhweltd@yahoo.com
Neros Pharmaceuticals LimitedAddress: 36, Akin Adesola Street Victoria Island, Lagos. G.P.O. Box 7888,
Marina, Lagos.
Phone: +234 (0) 803 328 7447, 803 578 2355 , 803 578 2302, 803 356 9048.
Email: info@nerospharma.com
Website: http://www.nerospharma.com
Nigerian German ChemicalsAddress: Plot 144, Oba Akran Avenue, P.O. Box 261 Ikeja Lagos
Phone: +234 1 496 8220-9;
Fax: +234 1 496 0482.
Email: enquiries@ngcplc.com
Website: http://www.ngcplc.com
Novel Drugs LimitedAddress: Km 14, Ikorodu Road, Owode-Onirin, P.O.Box 3288,
Ikeja, Lagos.
Phone : +234 1 815 0800, (0) 802 332 3359.
Email: novel@hyperia.com
Orange Drugs LimitedAddress: Plot 66/68, Town Planning Way, Ilupeju, Lagos.
Phone: +234 1 496 0036, 493 7526, 493 7528, 493 7507-9;
Fax: +234 1 493 7543.
Email: orangr@orangegroups.com
Website: http://www.orangegroups.com
Pharchem Industries LimitedAddress:Plot J, Industrial Street, Ilupeju, P.M.B. 21211,
Ikeja, Lagos.
Phone: +234 1 496 1004, 496 3505;
Fax: +234 1 496 3505.
Email: pharchem2003@yahoo.com
Ranbaxy Nigeria LimitedAddress: 24, Abimbola Street, Ilasmaja, Isolo, Lagos.
Phone: +234 1 452 7094; Fax: +234 1 452 6371.
Email: business@ranbaxynigeria.com
Website: http://www..ranbaxy.com
Reals Pharmaceuticals LimitedAddress: Reals Plaza, Plot 1, Alhaji Dosunmu Street, CBD Alausa,
Ikeja , Lagos.
Phone: +234 1 774 1205.
Email: reals@realsgroup.com
Website: http://www.realsgroup.com
Silva Hill Pharma LimitedAddress: 55, Urubi Street, P.O. Box 4784, Benin City,
Edo State.
Phone: +234 5 225 7174.
SKG Pharma Limited (former Wellcome Nigeria Limited)Address: Wellcome House, 2, Oba Akran Avenue, P.M.B. 21099,
Ikeja, Lagos.
Phone: +234 1 496 2718, 496 1856, 496 1745, 496 0841;
Fax: +234 1 496 2671.
Email: oakpa@rumon-nigeria.com
Summit Healthcare Pharm. LimitedAddress: 32, Sabo Arobiodu Street, G.R.A., Ikeja, P.O. Box 2680,
Yaba, Lagos.
Phone: +234 1 493 6667, 496 75791;
Fax: +234 1 493 8142.
Supreme Pharmaceuticals LimitedAddress: 18, Ilupeju Bye-Pass, Ilupeju, Lagos.
Phone: +234 1 452 5639, 587 0304, 587 0307.
Swiss Pharma Nigeria Limited (Swipha)Address: 5, Dopemu Road, Agege, Lagos.
Phone: +234 1 761 5202, (0) 803 717 6137;
Fax: +234 1 492 1974, 492 5131.
Email: swipha@swiphanigeria.com
Website: http://www.swiphanigeria.com
Taylek Drugs Company LimitedAddress: Plot 8, Block ‘M’, Abimbola Street, Isolo, Lagos.
Phone: +234 1 452 5961, 452 6037;
Fax: +234 1 452 8797.
Tisco Industries LimitedAddress: Tisco Plaza, Plot 6, Block B, Central Business District,
Alausa – Ikeja, Lagos.
Phone: +234 1 493 2845; Fax: +234 1 493 2844 .
Email: tisconigeria@yahoo.com
Website: http://www.tiscoindustries.com
Topway Pharmaceuticals LimitedAddress: Iperu-Ilisan Road, Ilisa, Ogun State.
Phone: +234 1 269 4699;
Fax: +234 1 269 4699.
Ugolab Production LimitedAddress: 157/159, Club Road, Bompai, Kano.
Phone: +234 (0) 803 703 9789, 802 309 4219;
Fax: +234 6 463 8237.
Email: ugolabpharm@yahoo.com
Ulticare-Lyka Pharma. Limited.Address: Plot 8, Akanbi-Onitiri Street, Off Eric Moore Road,
Igamu, Lagos.
Phone: +234 1 264 6746, 545 6074;
Fax: +234 1 545 4144.
Email: ulticare@chrismatel.com
Website: http://www.chrismatel.com
Unique Pharmaceuticals LimitedAddress: 11, Fatai Atere Way, Matori, Mushin, Lagos.
Phone: +234 1 452 3977, 452 0290, 452 0658, 774 0161;
Fax: +234 1 452 4028, 261 5782.
Email: unique@cybaaspace.net
Vitabiotics Nigeria LimitedAddress: 35, Mobolaji Johnson Avenue, Oregun Industrial Estate,
Ikeja, Lagos.
Phone: +234 1 497 3717, 497 3718;
Fax: +234 1 496 0852.
Email: ugolabpharm@yahoo.com
Vital Pharm. & Healthcare LimitedAddress: 28, Ajasa Street, Onikan, Lagos.
Phone: +234 1 263 6411, 263 3485, 263 6449;
Fax: +234 1 263 6298, 263 6678.
Zoomota Nigeria Limited
Address: 2B, Ilojo Crescent, Savoil Bus Stop, Ikorodu Road,
Obanikoro, Lagos.
Phone: +234 1 497 6870, 773 8847 ;
Fax: +234 1 493 0107.
Email: customercare@zoomotaltd.com
Website: http://www.zoomota.com
Thursday, 23 August 2012
Very Common Diabetes Drug Raises Risk Of Bladder Cancer
New research published in the Journal of the National Cancer Institute
has found that a popular class of diabetes drug increases people's risk of
developing bladder cancer.
According to researchers from the Perelman School of Medicine at the University of Pennsylvania, the drug that accounts for up to 20% of the medication prescribed to diabetics in the U.S., thiazolidinedione (TZDs), gives patients a 2 to 3 times greater likelihood of developing bladder cancer than those taking a sulfonylurea drug, another common class of medication for diabetics.
Diabetes patients are already known to have a slightly greater chance of developing this cancer as compared to the general population, which the authors suggest makes this finding especially important. About 40 out of 100,00 diabetics typically eventually develop cancer of the bladder, versus 30 in 100,000 out of the general population.
Sixty thousand type 2 diabetics from the Health Improvement Network (THIN) database in the United Kingdom were observed in the study.
Authors found that people treated with the TZD drugs, pioglitazone (Actos) or rosiglitzaone (Avandia), had a 2 to 3 fold increase in the risk of bladder cancer after 5 or more years taking the drug, as opposed to those who took sulfonylurea drugs, like glipizide (Glucotrol).
The experts' analysis showed that 170 patients per 100,000 taking TZDs, for 5 or more years, were expected to develop this disease. For those taking sulfonylurea drugs, about 60 in 100,000 would develop bladder cancer.
Ronac Mamtani, MD, the study's lead author, an instructor in the division of Hematology-Oncology in Penn's Abramson Cancer Center, explained:
Ever since Avandia became linked to severe cardiovascular problems, the majority of people in the United States no longer take it.
However, about 15 million prescriptions are written for Actos each year; it is the 9th most popular prescribed drug in the nation. This drug is usually chosen when Metformin, the first-line diabetes drug, can no longer control the illnesses of type 2 diabetes patients.
Germany and France have already taken Actos off the market, and the FDA has even warned that it may be associated with a risk of bladder cancer because of evidence in previous research.
This new finding should rule out the entire class of TZDs, as this was one of the first studies to analyze the risk of bladder cancer among patients taking either TZDs or sulfonylurea drugs.
Mamtani concluded:
Written by Sarah Glynn
According to researchers from the Perelman School of Medicine at the University of Pennsylvania, the drug that accounts for up to 20% of the medication prescribed to diabetics in the U.S., thiazolidinedione (TZDs), gives patients a 2 to 3 times greater likelihood of developing bladder cancer than those taking a sulfonylurea drug, another common class of medication for diabetics.
Diabetes patients are already known to have a slightly greater chance of developing this cancer as compared to the general population, which the authors suggest makes this finding especially important. About 40 out of 100,00 diabetics typically eventually develop cancer of the bladder, versus 30 in 100,000 out of the general population.
Sixty thousand type 2 diabetics from the Health Improvement Network (THIN) database in the United Kingdom were observed in the study.
Authors found that people treated with the TZD drugs, pioglitazone (Actos) or rosiglitzaone (Avandia), had a 2 to 3 fold increase in the risk of bladder cancer after 5 or more years taking the drug, as opposed to those who took sulfonylurea drugs, like glipizide (Glucotrol).
The experts' analysis showed that 170 patients per 100,000 taking TZDs, for 5 or more years, were expected to develop this disease. For those taking sulfonylurea drugs, about 60 in 100,000 would develop bladder cancer.
Ronac Mamtani, MD, the study's lead author, an instructor in the division of Hematology-Oncology in Penn's Abramson Cancer Center, explained:
"Diabetes is one the most common chronic diseases worldwide, affecting 285 million people. There are many factors clinicians must weigh in deciding which drug to use to control a patient's diabetes, and these new data provide important information to include in that decision-making process. Our study shows that doctors who care for patients with diabetes should be very aware of any bladder-related symptoms patients might be having, like blood in the urine, and take steps to further evaluate those issues."
Ever since Avandia became linked to severe cardiovascular problems, the majority of people in the United States no longer take it.
However, about 15 million prescriptions are written for Actos each year; it is the 9th most popular prescribed drug in the nation. This drug is usually chosen when Metformin, the first-line diabetes drug, can no longer control the illnesses of type 2 diabetes patients.
Germany and France have already taken Actos off the market, and the FDA has even warned that it may be associated with a risk of bladder cancer because of evidence in previous research.
This new finding should rule out the entire class of TZDs, as this was one of the first studies to analyze the risk of bladder cancer among patients taking either TZDs or sulfonylurea drugs.
Mamtani concluded:
"The risk does seem to be common among both drugs in the TZD class, and the fact that we have compared bladder cancer risk among patients taking each of those drugs provides essential information, because a safety warning on a drug is only useful to a doctor when they have knowledge of the same risks for an alternative drug. We believe our study will help doctors and their patients weigh the potential benefits and risks when selecting between different diabetes medication."
Written by Sarah Glynn
Culled from Medical News Today
Subscribe to:
Posts (Atom)